Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.

(Thrombosis research, v196:432-434)
Read publication

Overview publication

TitleAnti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.
Date2020-12-01
Issue nameThrombosis research
Issue numberv196:432-434
DOI10.1016/j.thromres.2020.09.039
PubMed33049598
AuthorsTrunfio M, Salvador E, Cabodi D, Marinaro L, Alcantarini C, Gaviraghi A, Trentalange A, Lipani F, Sciascia S, Roccatello D, Bonora S, Di Perri G & Calcagno A
KeywordsActivated factor X, COVID-19, Clinical outcome, Heparin, low molecular weight heparin, and related compounds, SARS-CoV-2
Read Read publication